GottwaldMDBainbridgeJLDowlingGAAminoffMJAlldredgeBK. New pharmacotherapy for Parkinson's disease. Ann Pharmacother1997;31: 1205–17.
2.
DingemanseJJorgaKZürcherGSchmittMSedekGDa PradaNPharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose levodopa. Br J Clin Pharmacol1995;40:253–62.
3.
Withdrawal of tolcapone. CSM current problems in. pharmacovigilance.1999;25: 2.
4.
KovacsSO. Vitiligo. J Am Acad Dermatol1998;38: 647–66.
5.
LernerAB. On the etiology of vitiligo and gray hair. Am J Med1971;51: 141–7.
